Pharmesis International Ltd. provided earnings guidance for the second half and financial year ended 31 December 2021. The Group expected to report a net profit for the unaudited financial results for the second half and financial year ended 31 December 2021 as compared to a net loss for the corresponding periods for the second half and financial year ended 31 December 2020. The expected net profit was mainly attributed to higher other income and lower costs in the second half and financial year ended 31 December 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 SGD | -5.41% | -5.41% | +7.14% |
1st Jan change | Capi. | |
---|---|---|
+7.14% | 2.14M | |
+30.38% | 684B | |
+29.61% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.42% | 240B | |
+9.58% | 208B | |
-7.24% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- BFK Stock
- News Pharmesis International Ltd.
- Pharmesis International Ltd. Provides Earnings Guidance for the Second Half and Financial Year Ended 31 December 2021